Literature DB >> 31967727

Endometriosis fertility index for predicting non-assisted reproductive technology pregnancy after endometriosis surgery: a systematic review and meta-analysis.

S Vesali1, M Razavi2, M Rezaeinejad3, A Maleki-Hajiagha4, S Maroufizadeh5, M Sepidarkish6,7.   

Abstract

BACKGROUND: Results of studies that have assessed the accuracy of the endometriosis Fertility Index (EFI) for predicting non-assisted reproductive technology (ART) pregnancy are inconsistent.
OBJECTIVE: We intended to evaluate the accuracy of EFI for the prediction of non-ART pregnancy. SEARCH STRATEGY: Embase, Medline, Scopus and Web of Science were searched up to 5 October 2019. SELECTION CRITERIA: We included studies that used EFI to predict non-ART pregnancy in women with surgically documented endometriosis. DATA COLLECTION AND ANALYSIS: A total of 5547 studies were identified, from which we included 17 studies on 4598 women in the meta-analysis. Eight studies were classified as good quality, and the rest were considered to be of fair quality. Only five (29.41%) studies used appropriate approaches to account for potential confounders. Pooled effect sizes with corresponding 95% CI were calculated using random-effects model. MAIN
RESULTS: The cumulative non-ART pregnancy rate at 36 months was 10% (95% CI: 3, 16%; P < 0.001) for women with an EFI of 0-2, which significantly increased to 69% (95% CI: 58, 79%; P < 0.001) for women with an EFI of 9-10. Compared with women with an EFI of 3-4 (18%, 95% CI: 12, 24%; P < 0.001), the combined cumulative non-ART pregnancy rates were 44% (95% CI: 26, 63%; P < 0.001) for women with an EFT of 5-6 and 55% (95% CI: 47, 64%; P < 0.001) for women with an EFI of 7-8. Paired comparison by the chi-square test showed a significant difference between all categories (P < 0.001). The odds ratio (OR) for EFI was 1.33 (95% CI: 1.17, 1.49, P < 0.001) and the summary area under the curve (AUC) was 72% (95% CI: 65, 80%, P < 0.001).
CONCLUSION: The current findings highlighted the good performance of the EFI score in predicting the non-ART pregnancy rate. However, these findings should be considered with caution because of the substantial heterogeneity between studies. TWEETABLE ABSTRACT: Review findings show the merits of Endometriosis Fertility Index as having a prognostic ability for non-assisted reproductive technology pregnancy.
© 2020 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Endometriosis Fertility Index; meta-analysis; pregnancy; systematic review

Year:  2020        PMID: 31967727     DOI: 10.1111/1471-0528.16107

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  4 in total

1.  Infertility management according to the Endometriosis Fertility Index in patients operated for endometriosis: What is the optimal time frame?

Authors:  Alexandre Bailleul; Julien Niro; Joseph Du Cheyron; Pierre Panel; Arnaud Fauconnier
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

2.  Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification.

Authors:  Nathalie Vermeulen; Mauricio S Abrao; Jon I Einarsson; Andrew W Horne; Neil P Johnson; Ted T M Lee; Stacey Missmer; John Petrozza; Carla Tomassetti; Krina T Zondervan; Grigoris Grimbizis; Rudy Leon De Wilde
Journal:  Hum Reprod Open       Date:  2021-10-22

3.  Reproductive and postsurgical outcomes of infertile women with deep infiltrating endometriosis.

Authors:  Ning Zhang; Shugen Sun; Yunxi Zheng; Xiaofang Yi; Junjun Qiu; Xiaodan Zhang; Ying Zhang; Keqin Hua
Journal:  BMC Womens Health       Date:  2022-03-21       Impact factor: 2.809

4.  Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification.

Authors:  N Vermeulen; M S Abrao; J I Einarsson; A W Horne; N P Johnson; T T M Lee; S Missmer; J Petrozza; C Tomassetti; K T Zondervan; G Grimbizis; R L De Wilde
Journal:  Facts Views Vis Obgyn       Date:  2021-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.